Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Cosmeceuticals are basically 'hope in a jar'
New Orleans - Before solid research establishes their validity, "cosmeceuticals" should be considered "hope in a jar," according to Leslie Baumann, M.D. In discussing the burgeoning field, where cosmetic products are reputed to have biologic effects, Dr. Baumann separated myth from fact at the American Academy of Dermatology annual meeting.
Related Videos
Related Content
